Wed, December 12, 2018
Tue, December 11, 2018
Mon, December 10, 2018
Fri, December 7, 2018

Sumant Kulkarni Initiated (ACAD) at Hold and Held Target at $23 on, Dec 10th, 2018

  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. hold-and-held-target-at-23-on-dec-10th-2018.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Sumant Kulkarni of Canaccord Genuity, Initiated "ACADIA Pharmaceuticals Inc." (ACAD) at Hold and Held Target at $23 on, Dec 10th, 2018.

Sumant has made no other calls on ACAD in the last 4 months.



There are 2 other peers that have a rating on ACAD. Out of the 2 peers that are also analyzing ACAD, 0 agree with Sumant's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Sumant


  • Charles Duncan of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $30 on, Thursday, November 1st, 2018
  • Tazeen Ahmad of "B of A Securities" Maintained at Strong Buy with Increased Target to $25 on, Wednesday, October 10th, 2018